Literature DB >> 26148590

Low titer of antibody against Toxoplasma gondii may be related to resistant to cancer.

Maryam Sharafi Seyedeh, Salehi Nahid, Mortazavi Nahid, Danesh Pour Shima, Yousefi Morteza, Yousofi Darani Hossein1.   

Abstract

CONTEXT: Toxoplasma gondii is a protozoan parasite with a world-wide distribution. However, the majority of infected cases remain symptomless. There are raising scientific evidences indicating that parasitic infections induce antitumor activity against certain types of cancers. The inhibitory effect of T. gondii on cancer growth has also been shown in cell culture and mouse model. AIMS: Considering the anti-tumor effect of this parasite, in this study the relationship between low titer of antibodies against T. gondii and resistant to cancers has been investigated. SUBJECTS AND METHODS: In two separate experiments, anti T. gondii antibody was estimated in 150 patients with cancer and 120 normal people. STATISTICAL ANALYSIS USED: Chi-square test was used for data analysis.
RESULTS: The frequency of low titer antibody against Toxoplasma gondii in cancer patients was significantly higher than the frequency of low-titer antibody against this parasite in normal people.
CONCLUSIONS: Exposure to T. gondii may be related to resistance to cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26148590     DOI: 10.4103/0973-1482.144638

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  4 in total

1.  A lentiviral vaccine expressing KMP11-HASPB fusion protein increases immune response to Leishmania major in BALB/C.

Authors:  Nahid Mortazavidehkordi; Ali Fallah; Abbas Abdollahi; Vahid Kia; Hossein Khanahmad; Zahra Ghayour Najafabadi; Nooshin Hashemi; Bahareh Estiri; Zahra Roudbari; Ali Najafi; Akbar Farjadfar; Seyed Hossein Hejazi
Journal:  Parasitol Res       Date:  2018-05-29       Impact factor: 2.289

2.  Comment to: Serologic evidence of Toxoplasma gondii infection among cancer patients. A prospective study from Qassim region, Saudi Arabia.

Authors:  Mahmood D Al-Mendalawi
Journal:  Saudi Med J       Date:  2017-06       Impact factor: 1.484

Review 3.  Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth.

Authors:  Jiating Chen; Wenzhong Liao; HongJuan Peng
Journal:  Front Cell Infect Microbiol       Date:  2022-08-31       Impact factor: 6.073

4.  Seroprevalence and risk factors of Toxoplasma gondii infection in oral cancer patients in China: a case-control prospective study.

Authors:  N Zhou; X Y Zhang; Y X Li; L Wang; L L Wang; W Cong
Journal:  Epidemiol Infect       Date:  2018-07-13       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.